NITROFIX SR Isosorbide Mononitrate 30mg Prolonged Release Tablet 1's
RXDRUG-DRP-7996-30-1pc
- View all variations as list
| CODE | Dosage Strength | Drug Packaging | Availability | Price | ||
|---|---|---|---|---|---|---|
|
RXDRUG-DRP-7996-30-1pc
|
In stock
|
₱1300 | |||
|
RXDRUG-DRP-7996-1pc
|
In stock
|
₱1500 |
Discreet Packaging
We recognize that purchasing medications can be a deeply personal matter. To respect your privacy, we ensure that all orders are packaged discreetly, with no indication of the contents on the packaging. This means that even our couriers remain unaware of the package contents.
Furthermore, we uphold strict confidentiality standards. We guarantee that your order information will never be disclosed to any third party. Your trust is paramount to us, and we are committed to safeguarding your privacy at every step of the process. Our dedication to discretion and confidentiality is part of our unwavering commitment to you, our valued customer.
FDA-registered Products
FDA-licensed Pharmacies
Sellers of this product
Features
Brand
Nitrofix SR
Full Details
Dosage Strength
30 mg
Drug Ingredients
- Isosorbide Mononitrate
Drug Packaging
Prolonged Release Tablet 1's
Generic Name
Isosorbide Mononitrate
Dosage Form
Prolonged Release Tablet
Registration Number
DRP-7996
Drug Classification
Prescription Drug (RX)
Description
Indications
Used to prevent and treat Angina.
Dosage
Initially, 30-60 mg once daily in the morning. Doses may be increased to 120 mg once daily if necessary. Use the lowest effective dose.
Administration
Should be taken on an empty stomach.
Contraindications
Severe hypotension, hypertrophic obstructive cardiomyopathy, constrictive pericarditis, cardiac tamponade, aortic or mitral valve stenosis, acute circulatory failure/shock, circulatory collapse, cardiogenic shock, acute MI with low left ventricular filling pressure, conditions associated with increased intracranial pressure (e.g. cerebral haemorrhage, head trauma), closed-angle glaucoma, marked anaemia, hypovolaemia. Concomitant use with phosphodiesterase-5 (PDE-5) inhibitors (e.g. sildenafil) or riociguat.
Special Precautions
Patient with recent history of MI, inferior wall MI and suspected right ventricular infarctions; hypothyroidism, hypoxaemia, malnutrition, hypothermia. Not indicated for the treatment of acute angina attacks. Avoid abrupt withdrawal. Severe renal and hepatic impairment. Elderly. Pregnancy and lactation.
Storage
Store between 20-30°C. Protect from light and moisture.
MedsGo Class
Anti-Anginal Drugs
Please sign in so that we can notify you about a reply